141 related articles for article (PubMed ID: 31069822)
1. Noninvasive assessment of fetal central nervous system insult: Potential application to prenatal diagnosis.
Goetzl L; Darbinian N; Merabova N
Prenat Diagn; 2019 Jul; 39(8):609-615. PubMed ID: 31069822
[TBL] [Abstract][Full Text] [Related]
2. Ethanol Exposure Increases miR-140 in Extracellular Vesicles: Implications for Fetal Neural Stem Cell Proliferation and Maturation.
Tseng AM; Chung DD; Pinson MR; Salem NA; Eaves SE; Miranda RC
Alcohol Clin Exp Res; 2019 Jul; 43(7):1414-1426. PubMed ID: 31009095
[TBL] [Abstract][Full Text] [Related]
3. Fetal Brain-Derived Exosomal miRNAs from Maternal Blood: Potential Diagnostic Biomarkers for Fetal Alcohol Spectrum Disorders (FASDs).
Darbinian N; Hampe M; Martirosyan D; Bajwa A; Darbinyan A; Merabova N; Tatevosian G; Goetzl L; Amini S; Selzer ME
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892014
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21.
Lim JH; Lee DE; Kim SY; Kim HJ; Kim KS; Han YJ; Kim MH; Choi JS; Kim MY; Ryu HM; Park SY
J Assist Reprod Genet; 2015 May; 32(5):827-37. PubMed ID: 25749789
[TBL] [Abstract][Full Text] [Related]
5. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
[TBL] [Abstract][Full Text] [Related]
6. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions.
Keravnou A; Ioannides M; Tsangaras K; Loizides C; Hadjidaniel MD; Papageorgiou EA; Kyriakou S; Antoniou P; Mina P; Achilleos A; Neofytou M; Kypri E; Sismani C; Koumbaris G; Patsalis PC
Genet Res (Camb); 2016 Nov; 98():e15. PubMed ID: 27834155
[TBL] [Abstract][Full Text] [Related]
9. Novel biomarkers to assess in utero effects of maternal opioid use: First steps toward understanding short- and long-term neurodevelopmental sequelae.
Goetzl L; Thompson-Felix T; Darbinian N; Merabova N; Merali S; Merali C; Sanserino K; Tatevosian T; Fant B; Wimmer ME
Genes Brain Behav; 2019 Jul; 18(6):e12583. PubMed ID: 31119847
[TBL] [Abstract][Full Text] [Related]
10. A metabolomics-based approach for non-invasive screening of fetal central nervous system anomalies.
Troisi J; Landolfi A; Sarno L; Richards S; Symes S; Adair D; Ciccone C; Scala G; Martinelli P; Guida M
Metabolomics; 2018 May; 14(6):77. PubMed ID: 30830338
[TBL] [Abstract][Full Text] [Related]
11. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
[TBL] [Abstract][Full Text] [Related]
12. First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR.
Hromadnikova I; Kotlabova K; Ivankova K; Krofta L
PLoS One; 2017; 12(2):e0171756. PubMed ID: 28182660
[TBL] [Abstract][Full Text] [Related]
13. Impact of introduction of noninvasive prenatal testing on uptake of genetic testing in fetuses with central nervous system anomalies.
Al Toukhi S; Chitayat D; Keunen J; Roifman M; Seaward G; Windrim R; Ryan G; Van Mieghem T
Prenat Diagn; 2019 Jun; 39(7):544-548. PubMed ID: 31017676
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies.
Zaragoza E; Akolekar R; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):382-6. PubMed ID: 19277983
[TBL] [Abstract][Full Text] [Related]
15. Cyclic-recombinase-reporter mouse model to determine exosome communication and function during pregnancy.
Sheller-Miller S; Choi K; Choi C; Menon R
Am J Obstet Gynecol; 2019 Nov; 221(5):502.e1-502.e12. PubMed ID: 31207235
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
17. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?
Gerovassili A; Garner C; Nicolaides KH; Thein SL; Rees DC
Prenat Diagn; 2007 Feb; 27(2):104-10. PubMed ID: 17152117
[TBL] [Abstract][Full Text] [Related]
18. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of maternal circulating microRNAs as non-invasive biomarkers for prenatal diagnosis of congenital heart defects.
Gu H; Chen L; Xue J; Huang T; Wei X; Liu D; Ma W; Cao S; Yuan Z
Biomed Pharmacother; 2019 Jan; 109():823-830. PubMed ID: 30551536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
